Farrell, Ruth M.Pierce, MadelynCollart, ChristinaCraighead, CaitlinColeridge, MarissaChien, Edward K.Pemi, UmaFrankel, RichardRanzini, AngelaTucker Edmonds, Brownsyne2021-04-162021-04-162021Farrell, R. M., Pierce, M., Collart, C., Craighead, C., Coleridge, M., Chien, E. K., ... & Rose, S. S. (2021). The impact of the emergence of COVID‐19 on women's prenatal genetic testing decisions. Prenatal Diagnosis. https://doi.org/10.1002/pd.5902https://hdl.handle.net/1805/25667Objective We conducted a study to examine the impact of COVID on patients' access and utilization of prenatal genetic screens and diagnostic tests at the onset of the COVID‐19 pandemic in the United States. Methods We conducted telephone interviews with 40 patients to examine how the pandemic affected prenatal genetic screening and diagnostic testing decisions during the initial months of the pandemic in the United States. An interview guide queried experiences with the ability to access information about prenatal genetic testing options and to utilize the tests when desired. Audio recordings were transcribed and coded using NVivo 12. Analysis was conducted using Grounded Theory. Results The pandemic did not alter most participants' decisions to undergo prenatal genetic testing. Yet, it did impact how participants viewed the risks and benefits of testing and timing of testing. There was heightened anxiety among those who underwent testing, stemming from the risk of viral exposure and the fear of being alone if pregnancy loss or fetal abnormality was identified at the time of an ultrasound‐based procedure. Conclusion The pandemic may impact patients' access and utilization of prenatal genetic tests. More research is needed to determine how best to meet pregnant patients' decision‐making needs during this time.enPublisher PolicyCOVID-19prenatal genetic screensdiagnostic testsArticle